Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

NCT02673788 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2019-04-09

No results posted yet for this study

Summary

This is a follow-up study of the open label, single-center, phase I clinical trial to evaluate the safety of Pneumostem® in premature infants with Intraventricular hemorrhage.

Conditions

  • Intracranial Hemorrhages
  • Mesenchymal Stem Cells
  • Newborn Infant

Interventions

OTHER

observation without intervention in this follow up study

observation without intervention in this follow up study

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02673788 on ClinicalTrials.gov